Getinge announces today the acquisition of 100% of the shares of Quadralene. Quadralene is a global manufacturer of, and expert in, decontamination products such as detergents and disinfectants for the health care and dental sector. Quadralene has annual net sales of approximately SEK 75 M and will be a part of Infection Control in the business area of Surgical Workflows.

Getinge is investing 3 Million Euros in its manufacturing of polyester grafts and patches to treat aneurysmal and occlusive diseases. The investment aims at increasing manufacturing capacity in Getinge’s site in La Ciotat, France.